1032943-41-1 Usage
General Description
4-bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine is a chemical compound referred to by an IUPAC name with an associated molecular formula of C8H7BrN4. This chemical substance belongs to the group of heterocyclic compounds class specifically pyrazolopyridines, which host one or two similar or different heteroatoms in their structure. The physical characteristics, potential uses, or safety information related to the toxicity, flammability or impact on the environment for this compound may not be readily available. In general, such compounds can be utilized in a wide range of applications including the development of pharmaceutical drugs, research in medicinal chemistry, and other industrial chemical processes. However, the specific role and properties of 4-bromo-1-methyl-1H-pyrazolo[3,4-c]pyridine may differ depending on their chemical small modifications.
Check Digit Verification of cas no
The CAS Registry Mumber 1032943-41-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,2,9,4 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1032943-41:
(9*1)+(8*0)+(7*3)+(6*2)+(5*9)+(4*4)+(3*3)+(2*4)+(1*1)=121
121 % 10 = 1
So 1032943-41-1 is a valid CAS Registry Number.
1032943-41-1Relevant articles and documents
CYCLOALKANE-1,3-DIAMINE DERIVATIVE
-
Paragraph 1320-1323, (2021/09/03)
The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.
Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
-
Page/Page column 27; 31, (2009/07/10)
The invention relates to alkynylaryl compounds according to the general formula (I) : in which A, B, D, E, Ra, R1, R3, R4, R5 and q are as defined in the claims, and salts, N-oxides, solvates and prod